Protodynamic therapy for bladder cancer: in vitro results of a novel treatment concept

被引:9
作者
Laihia, Jarmo K. [1 ]
Pylkkanen, Liisa [1 ,2 ]
Laato, Matti [3 ,4 ]
Bostrom, Peter J. [4 ]
Leino, Lasse [1 ]
机构
[1] BioCis Pharma Ltd, FI-20520 Turku, Finland
[2] Univ Turku, Dept Oncol, Turku, Finland
[3] Univ Turku, Dept Med Biochem, Turku, Finland
[4] Turku Univ, Cent Hosp, Dept Surg, Div Urol, Turku, Finland
关键词
urinary bladder neoplasms; cell proliferation; drug pulse therapies; combined antineoplastic agents; UROCANIC ACID ISOMERS; INTRACELLULAR PH; CHEMOTHERAPY;
D O I
10.1111/j.1464-410X.2009.08611.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE To present a novel treatment approach for urinary bladder cancer, protodynamic therapy, which comprises inhibition of cancer cell proliferation by intracellular acidification; cis-urocanic acid (cis-UCA) was investigated as a protodynamic drug in bladder cancer cell cultures and compared with conventional chemotherapeutic agents. MATERIALS AND METHODS The moderately differentiated cell line 5637 and the poorly differentiated T24 cell line were exposed to cis-UCA for 0.25-2 h, and to epirubicin, doxorubicin, cisplatin and paclitaxel for 2 h, to simulate drug exposure on intravesical instillation. The combination of cis-UCA and chemotherapeutic agents was also studied. Cell viability was measured with a colorimetric assay. RESULTS cis-UCA inhibited proliferation and suppressed the survival of cells at an extracellular pH < pK(a2) of 6.65 but to a lesser degree at pH > pK(a2), as suggested by the protodynamic theory. cis-UCA caused dose-dependent, irreversible termination of cell proliferation. The number of viable surviving BC cells decreased by > 85% with 2% cis-UCA (P < 0.001). Viable cells disappeared completely with 4% and 6% cis-UCA after a 2-h treatment, and by 90% with 6% cis-UCA within a 15-min exposure. These effects were associated with distinct morphological changes. The other drugs tested had a clearly lower effect on cell survival. Interestingly, when combined, cis-UCA markedly enhanced the cytotoxic effect of epirubicin. CONCLUSION cis-UCA is a potent antiproliferative agent in bladder cancer cell cultures. As our previous non-clinical studies showed that cis-UCA is locally and systemically well tolerated, protodynamic therapy with cis-UCA is a promising intravesical treatment for bladder cancer.
引用
收藏
页码:1233 / 1238
页数:6
相关论文
共 18 条
[1]   INVESTIGATION OF THE RELATIONSHIP BETWEEN ALTERED INTRACELLULAR PH AND MULTIDRUG RESISTANCE IN MAMMALIAN-CELLS [J].
BOSCOBOINIK, D ;
GUPTA, RS ;
EPAND, RM .
BRITISH JOURNAL OF CANCER, 1990, 61 (04) :568-572
[2]   MRI of the tumor microenvironment [J].
Gillies, RJ ;
Raghunand, N ;
Karczmar, GS ;
Bhujwalla, ZM .
JOURNAL OF MAGNETIC RESONANCE IMAGING, 2002, 16 (04) :430-450
[3]  
GROOS E, 1986, CANCER-AM CANCER SOC, V58, P1199, DOI 10.1002/1097-0142(19860915)58:6<1199::AID-CNCR2820580604>3.0.CO
[4]  
2-Z
[5]   Paclitaxel and cisplatin as intravesical agents against non-muscle-invasive bladder cancer [J].
Hadaschik, Boris A. ;
ter Borg, Melanie G. ;
Jackson, John ;
Sowery, Richard D. ;
So, Alan I. ;
Burt, Helen M. ;
Gleave, Martin E. .
BJU INTERNATIONAL, 2008, 101 (11) :1347-1355
[6]   Guideline for the management of nonmuscle invasive bladder cancer (Stages Ta, T1, and Tis): 2007 update [J].
Hall, M. Craig ;
Chang, Sam S. ;
Dalbagni, Guido ;
Pruthi, Raj Som ;
Seigne, John Derek ;
Skinner, Eila Curlee ;
Wolf, J. Stuart, Jr. ;
Schellhammer, Paul F. .
JOURNAL OF UROLOGY, 2007, 178 (06) :2314-2330
[7]   Intravesical pH: a potentially important variable affecting efficacy and the further development of anthracycline chemotherapy for superficial bladder cancer [J].
Harris, NM ;
Duffy, PM ;
Crook, TJ ;
Anderson, WR ;
Sharpe, P ;
Hayes, MC ;
Cooper, AJ ;
Solomon, LZ .
BJU INTERNATIONAL, 2002, 90 (09) :957-964
[8]   Determination of the dissociation constants of urocanic acid isomers in aqueous solutions [J].
Juusola, Pekka ;
Minkkinen, Pentti ;
Leino, Lasse ;
Laihia, Jarmo K. .
MONATSHEFTE FUR CHEMIE, 2007, 138 (10) :951-965
[9]  
Kallio J, 2006, J INVEST DERMATOL, V126, P40
[10]   Oxidative breakdown and conversion of urocanic acid isomers by hydroxyl radical generating systems [J].
Kammeyer, A ;
Eggelte, TA ;
Overmars, H ;
Bootsma, A ;
Bos, JD ;
Teunissen, MBM .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2001, 1526 (03) :277-285